Details of the Drug

General Information of Drug (ID: DM04DRQ)

Drug Name

Mical

Synonyms

Cetrimonium bromide; 57-09-0; Hexadecyltrimethylammonium bromide; Cetyltrimethylammonium bromide; CTAB; Centimide; CETAB; Bromat; Ctmab; Cee dee; Hexadecyl trimethyl ammonium bromide; Trimethylcetylammonium bromide; Cetyl trimethyl ammonium bromide; Cetaflon; Cetavlon; Lissolamine; Pollacid; Quamonium; Suticide; Cetarol; Micol; Cetrimide bp; Lissolamine A; Cetavlon bromide; Lissolamin V; N-Cetyltrimethylammonium bromide; Cetrimonium (bromide); Cycloton V; Cirrasol OD; Acetoquat CTAB; Softex KW; Cetrimonii bromidum; Hexadecyltrimethylammoniumbromide; Bromuro de cetrimonio; Trimethylhexadecylammonium bromide; Bromure de cetrimonium; N-HEXADECYLTRIMETHYLAMMONIUM BROMIDE; N,N,N-trimethylhexadecan-1-aminium bromide; (1-Hexadecyl)trimethylammonium bromide; Palmityltrimethyl ammonium bromide; N,N,N-Trimethylcetylammonium bromide; 1-Hexadecanaminium, N,N,N-trimethyl-, bromide; N,N,N-Trimethyl-1-hexadecanaminium bromide; UNII-L64N7M9BWR; N-Hexadecyl-N,N,N-trimethylammonium bromide; Cetrimonium Bromide (CTAB); MFCD00011772; CHEBI:3567; Palmityltrimethylammonium bromide; 1-Hexadecanaminium, N,N,N-trimethyl-, bromide (1:1); hexadecyl(trimethyl)azanium;bromide; 1-Hexadecyltrimethylammonium bromide; L64N7M9BWR; cetyl trimethylammonium bromide; CHEMBL307346; Lauroseptol; Hexadecyl-trimethyl-ammonium; bromide; NCGC00164283-01; Cetrimida; Cetrimidum; Cirrasol-OD; DSSTox_CID_17028; DSSTox_RID_79297; DSSTox_GSID_37028; Bromat (VAN); hexadecyltrimethylamine, bromide; Micol (VAN); Caswell No. 167; Lissolamine V (VAN); Cetavlex; Cradocap; Zetrimid; Cetrimide [INN:BAN:JAN]; Cetyltrimethylammonium (bromide);Hexadecyltrimethylammonium (bromide);CTAB; Cetrimonio bromuro; Cetrimonio bromuro [DCIT]; CAS-57-09-0; Hexadecyltrimethylammonium bromide, 99+%; CETYLTRIMETHYLAMMONIUM BROMIDE, 98%; CTABR; Cetrimonii bromidum [INN-Latin]; SR-05000001830; EINECS 200-311-3; Bromure de cetrimonium [INN-French]; Bromuro de cetrimonio [INN-Spanish]; NSC 32927; cetyltrimethylammoniumbromide; EPA Pesticide Chemical Code 069117; C19H42BrN; AI3-12209; Lissolamine V; cetyl N; Hexadecanyltrimethylammonium bromide; hexadecyl(trimethyl)azanium bromide; Cetrimonium bromide [INN:BAN:NF]; hexadecyl(trimethyl)ammonium bromide; Ammonium, hexadecyltrimethyl-, bromide; Epitope ID:116869; EC 200-311-3; SCHEMBL4377; ACMC-1AP33; Zephirol Related Compound 5; cetyltrimethyl ammonium bromide; cetyltrimethyl-ammonium bromide; SPECTRUM1503200; Cetrimonium bromide (NF/INN); cetyl trimethyl-ammonium bromide; hexadecyltrimethylazanium bromide; DTXSID5037028; HMS500K11; hexadecyl-trimethylammonium bromide; N,N-Trimethylcetylammonium bromide; HMS1922G21; HMS2092L22; HMS3652J19; Pharmakon1600-01503200; hexadecyl-trimethyl ammonium bromide; HY-B1260; NSC32927; Tox21_112096; Tox21_300853; ANW-32635; CCG-39968; NSC-32927; NSC758401; s4242; SBB008910; STL477543; AKOS015915119; Tox21_112096_1; CS-4893; JC10039; MCULE-7452998571; NSC-758401; Hexadecyltrimethylammonium bromide, 99%; N,N-Trimethyl-1-hexadecanaminium bromide; NCGC00095012-01; NCGC00095012-02; NCGC00164283-07; NCGC00254756-01; AK150860; AS-11739; BP-30064; N-Hexadecyl-N,N-trimethylammonium bromide; Q564; WLN: 16K1&1&1 &Q &E; Hexadecyltrimethylammonium bromide, >=98%; 1-Hexadecanaminium,N,N-trimethyl-, bromide; DB-050366; FT-0652251; FT-0655369; ST51046347; SW220088-1; A16438; C11275; D03454; Hexadecyltrimethylammonium bromide, AR, >=99%; A831309; Q416077; Hexadecyltrimethylammonium bromide, >=96.0% (AT); Hexadecyltrimethylammonium bromide, BioXtra, >=99%; Q-200821; SR-05000001830-1; SR-05000001830-3; Hexadecyltrimethylammonium bromide, analytical standard; UNII-24QSH2NL8N component LZZYPRNAOMGNLH-UHFFFAOYSA-M; Hexadecyltrimethylammonium bromide, BioUltra, >=99.0% (AT); Hexadecyltrimethylammonium bromide, for ion pair chromatography; Hexadecyltrimethylammonium bromide, for molecular biology, >=99%; Hexadecyltrimethylammonium bromide, Vetec(TM) reagent grade, 96%; Cetrimonium bromide, United States Pharmacopeia (USP) Reference Standard; Hexadecyltrimethylammonium bromide, BioUltra, for molecular biology, >=99.0% (AT); Hexadecyltrimethylammonium bromide, puriss. p.a., matrix substance for MALDI-MS; Hexadecyltrimethylammonium bromide, PharmaGrade, USP/NF, Manufactured under appropriate controls for pharma or biopharmaceutical production.

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Phase 2	[1]

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C19H42BrN
Canonical SMILES: CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-]
InChI: InChI=1S/C19H42N.BrH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4;/h5-19H2,1-4H3;1H/q+1;/p-1
InChIKey: LZZYPRNAOMGNLH-UHFFFAOYSA-M

Cross-matching ID

PubChem CID: 5974
ChEBI ID: CHEMBL3567
CAS Number: 57-09-0
TTD ID: DM5T2B

Drug-Molecule Activity Atlas (DMA)^NEW

Click to Jump to the Detailed DMA Information of This Drug

Drug ADMET Endpoint Profile (DAE)^NEW

Click to Jump to the Detailed DAE Information of This Drug

References

1	ClinicalTrials.gov (NCT02884544) A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD (HLD100-103). U.S. National Institutes of Health.